Your browser doesn't support javascript.
loading
Na+/H+-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cells.
Gong, Yao-Yu; Shao, Hongguang; Li, Yu; Brafford, Patricia; Stine, Zachary E; Sun, Jing; Felsher, Dean W; Orange, Jordan S; Albelda, Steven M; Dang, Chi V.
Afiliação
  • Gong YY; Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Shao H; The Wistar Institute, Philadelphia, PA, USA.
  • Li Y; Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
  • Brafford P; The Wistar Institute, Philadelphia, PA, USA.
  • Stine ZE; The Wistar Institute, Philadelphia, PA, USA.
  • Sun J; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Felsher DW; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Orange JS; Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
  • Albelda SM; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Dang CV; The Wistar Institute, Philadelphia, PA, USA.
Cancer Res Commun ; 2(8): 842-856, 2022 08.
Article em En | MEDLINE | ID: mdl-36380966
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Commun Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Commun Ano de publicação: 2022 Tipo de documento: Article